Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): An observational cohort study

The Lancet Infectious Diseases

Volumn 15, Issue 1, 2015, Pages 65-73

  Zou, Huachun ^a,b   Tabrizi, Sepehr N ^c,d,e   Grulich, Andrew E ^f   Hocking, Jane S ^b   Bradshaw, Catriona S ^b,g   Cornall, Alyssa M ^d,e   Morrow, Andrea ^a   Prestage, Garrett ^f,h   Law, Matthew G ^f   Garland, Suzanne M ^c,d,e   Chen, Marcus Y ^a,b,g   Fairley, Christopher K ^b,g  

^a MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

^e MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g MONASH UNIVERSITY   (Australia)

^h LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

ADOLESCENT; ADULT; ANAL HUMAN PAPILLOMAVIRUS INFECTION; ARTICLE; CLINICAL TRIAL; DISEASE TRANSMISSION; FOLLOW UP; HUMAN; INCIDENCE; MALE; MEN WHO HAVE SEX WITH MEN; OBSERVATIONAL STUDY; ORAL HUMAN PAPILLOMAVIRUS INFECTION; PAPILLOMAVIRUS INFECTION; PENILE HUMAN PAPILLOMAVIRUS INFECTION; PREVALENCE; ANUS DISEASES; AUSTRALIA; CLASSIFICATION; COHORT ANALYSIS; GENETICS; ISOLATION AND PURIFICATION; MALE HOMOSEXUALITY; MOUTH DISEASES; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PENILE DISEASES; YOUNG ADULT;

ADOLESCENT; ANUS DISEASES; AUSTRALIA; COHORT STUDIES; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MOUTH DISEASES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PENILE DISEASES; YOUNG ADULT;

EID: 84917695713     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70994-6     Document Type: Article

References (41)

1. Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011, 365:1576-1585.
2. Glick SN, Feng Q, Popov V, Koutsky LA, Golden MR High rates of incident and prevalent anal human papillomavirus infection among young men who have sex with men. J Infect Dis 2014, 209:369-376.
3. Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011, 364:401-411.
4. Diekmann O, Heesterbeek JA, Metz JA On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations. J Math Biol 1990, 28:365-382.
5. Ali H, Donovan B, Wand H, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 2013, 346:f2032.
6. Scherer A, McLean A Mathematical models of vaccination. Br Med Bull 2002, 62:187-199.
7. Goldstone S, Palefsky JM, Giuliano AR, et al. Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. J Infect Dis 2011, 203:66-74.
8. Zou H, Fairley CK, Hocking JS, Garland SM, Grulich AE, Chen MY The prevalence of anal human papillomavirus among young HIV negative men who have sex with men. BMC Infect Dis 2012, 12:341.
9. Zou H, Grulich AE, Cornall AM, et al. How very young men who have sex with men view vaccination against human papillomavirus. Vaccine 2014, 32:3936-3941.
10. Zou H, Tabrizi SN, Grulich AE, et al. Early acquisition of anogenital human papillomavirus among teenage men who have sex with men. J Infect Dis 2014, 209:642-651.
11. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989, 7:209-214.
12. Resnick RM, Cornelissen MT, Wright DK, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990, 82:1477-1484.
13. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991, 265:472-477.
14. Layton-Henry J, Scurry JS, Planner RS, et al. Cervical adenoid basal carcinoma, five cases and literature review. Int J Gynecol Cancer 1996, 6:193-199.
15. Schiffman M, Clifford G, Buonaguro FM Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer 2009, 4:8.
16. Ulm K A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 1990, 131:373-375.
17. Zou H, Prestage G, Fairley CK, et al. Sexual behaviors and risk for sexually transmitted infections among teenage men who have sex with men. J Adolesc Health 2014, 55:247-253.
18. Alvarez J, de Pokomandy A, Rouleau D, et al. Episomal and integrated human papillomavirus type 16 loads and anal intraepithelial neoplasia in HIV-seropositive men. AIDS 2010, 24:2355-2363. for the HIPVIRG Study Group.
19. Beachler DC, D'Souza G, Sugar EA, Xiao W, Gillison ML Natural history of anal vs oral HPV infection in HIV-infected men and women. J Infect Dis 2013, 208:330-339.
20. Darwich L, Cañadas MP, Videla S, et al. Oral human papillomavirus type-specific infection in HIV-infected men: a prospective cohort study among men who have sex with men and heterosexual men. Clin Microbiol Infect 2014, 20:O585-O589. for the Can Ruti HIV-HPV Team.
21. Darwich L, Cañadas MP, Videla S, et al. Prevalence, clearance, and incidence of human papillomavirus type-specific infection at the anal and penile site of HIV-infected men. Sex Transm Dis 2013, 40:611-618.
22. Darwich L, Cañadas MP, Videla S, et al. Condylomata, cytological abnormalities and human papillomavirus infection in the anal canal in HIV-infected men. HIV Med 2012, 13:549-557.
23. Parisi SG, Cruciani M, Scaggiante R, et al. Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men. BMC Infect Dis 2011, 11:150.
24. Phanuphak N, Teeratakulpisarn N, Pankam T, et al. Anal human papillomavirus infection among Thai men who have sex with men with and without HIV infection: prevalence, incidence, and persistence. J Acquir Immune Defic Syndr 2013, 63:472-479.
25. Phanuphak N, Teeratakulpisarn N, Triratanachat S, et al. High prevalence and incidence of high-grade anal intraepithelial neoplasia among young Thai men who have sex with men with and without HIV. AIDS 2013, 27:1753-1762.
26. van der Snoek EM, Niesters HG, van Doornum GJ, Mulder PG, Osterhaus AD, van der Meijden WI Acquisition and clearance of perianal human papillomavirus infection in relation to HIV-positivity in men who have sex with men in the Netherlands. Acta Derm Venereol 2005, 85:437-443.
27. Videla S, Darwich L, Cañadas MP, et al. Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men. Sex Transm Dis 2013, 40:3-10. for the HIV-HPV Study Group.
28. de Pokomandy A, Rouleau D, Ghattas G, et al. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis 2009, 199:965-973.
29. Nyitray AG, Carvalho da Silva RJ, Baggio ML, et al. Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. J Infect Dis 2011, 204:1711-1722.
30. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003, 157:218-226.
31. Burchell AN, Coutlée F, Tellier PP, Hanley J, Franco EL Genital transmission of human papillomavirus in recently formed heterosexual couples. J Infect Dis 2011, 204:1723-1729.
32. Read TR, Hocking JS, Vodstrcil LA, et al. Oral human papillomavirus in men having sex with men: risk-factors and sampling. PLoS One 2012, 7:e49324.
33. Jin F, Prestage GP, Kippax SC, et al. Risk factors for genital and anal warts in a prospective cohort of HIV-negative homosexual men: the HIM study. Sex Transm Dis 2007, 34:488-493.
34. Coseo SE, Porras C, Dodd LE, et al. Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure. Sex Transm Dis 2011, 38:976-982.
35. Vaccarella S, Franceschi S, Clifford GM, et al. Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2010, 19:2379-2388.
36. Paaso AE, Louvanto K, Syrjänen KJ, et al. Lack of type-specific concordance between human papillomavirus (HPV) serology and HPV DNA detection in the uterine cervix and oral mucosa. J Gen Virol 2011, 92:2034-2046.
37. Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012, 307:693-703.
38. Julia Brotherton. HPV vaccination for boys: the Australian experience. Presented at The Invisible Man, non-industry satellite session, HPV2014 29th Annual International Papillomavirus Conference, Aug 21-25, 2014; Seattle, WA, USA.
39. Tabrizi SN, Brotherton JM, Kaldor JM, et al. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. Lancet Infect Dis 2014, 14:958-966.
40. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011, 377:2085-2092.
41. Donovan B, Franklin N, Guy R, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011, 11:39-44.